《新股消息》移卡(09923.HK)上限定價16.64元 一手中籤率僅10%
移卡(09923.HK)公布招股結果,發售價定於16.64元,為上限定價(招股價介乎12.64至16.64元);公開發售錄超購640.38倍,經重新分配後,公開發售股數增至50%。每手400股,中籤率為10%。該股將於下周一(6月1日)掛牌,中信里昂、野村及農銀國際擔任聯席保薦人。
公司估計,集資淨額約15.28億元,其中20%用作於中國及海外市場實施銷售及營銷計劃,以擴展客戶群及增加交易量;35%用作擴展其科技賦能商業服務供應;35%用作提升研究及科技實力;餘下10%用作營運資金及其他一般公司用途。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.